LFG
ADMA icon

Larson Financial Group’s ADMA Biologics ADMA Stock Holding History

Larson Financial Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.24K Sell
692
-2,570
-79% -$40.6K ﹤0.01% 2490
2025
Q4 		$59.5K Buy
3,262
+2,876
+745% +$48.5K ﹤0.01% 1152
2025
Q3 		$5.66K Sell
386
-12
-3% -$206 ﹤0.01% 2313
2025
Q2 		$7.25K Buy
+398
New +$8.12K ﹤0.01% 1953
2024
Q4 		– Sell
-1,527
Closed -$30.5K – 2766
2024
Q3 		$30.5K Buy
+1,527
New +$23.7K ﹤0.01% 1063

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Larson Financial Group's ADMA Position: Q1 2026 in Review

Larson Financial Group reduced its ADMA Biologics (ADMA) stake by 79% in Q1 2026, selling an estimated $40.6K and leaving 692 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

Larson Financial Group first reported a position in ADMA in Q3 2024 and has held it in 5 quarters since. The position peaked at $59.5K in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Larson Financial Group held 692 shares of ADMA Biologics worth $6.24K as of Q1 2026.
  • Larson Financial Group sold 2,570 ADMA Biologics shares in Q1 2026, an estimated $40.6K.
  • ADMA Biologics made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2490 holding.
  • Larson Financial Group first reported a position in ADMA Biologics in Q3 2024 and has held it in 5 quarters since.
  • Larson Financial Group's ADMA Biologics position peaked at $59.5K in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.